skinny.

Latest / Lung Cancer Considered

FDA Approval: Zongertinib for HER2 Mutant NSCLC

FDA Approval: Zongertinib for HER2 Mutant NSCLC by IASLC

Log in to save or queue this episode.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.